Drawing based on the label description. No photo yet.
“Capsules, hard gelatin: 12.5 mg sunitinib: orange cap and orange body, printed with white ink "Pfizer" on the cap and "STN 12.5 mg" on the body. 25 mg sunitinib: caramel cap and orange body, printed with white ink "Pfizer" on the cap and "STN 25 mg" on the body. 37.5 mg sunitinib: yellow cap and yellow body, printed with black ink "Pfizer" on the cap and "STN 37.5 mg" on the body. 50 mg…”
Pfizer STN 12 5 mg pill
Pill with imprint Pfizer STN 12 5 mg is orange, capsule, 14 mm and has been identified as Sunitinib Malate 12.5 mg. It is used for renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors. It is supplied by Pfizer Laboratories Div Pfizer Inc.
Sunitinib Malate 12.5 mg
- Imprint
- Pfizer STN 12 5 mg
- Strength
- 12.5 mg
- Used for
- Renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors
- Color
- Orange
- Shape
- Capsule / oblong
- Size
- 14 mm
- Score
- No score line
- Form
- Capsule
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 0069-0550, 0069-0550-38
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Sunitinib Malate used for?
Sunitinib Malate is used for renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Gastrointestinal Stromal Tumor
Sunitinib malate capsules are indicated for the treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate.
Advanced Renal Cell Carcinoma
Sunitinib malate capsules are indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC).
Adjuvant Treatment of Renal Cell Carcinoma
Sunitinib malate capsules are indicated for the adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy.
Advanced Pancreatic Neuroendocrine Tumors
Sunitinib malate capsules are indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease.
From the FDA-approved label on DailyMed (published Sep 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows Pfizer STN 12 5 mg. The parts can be split between the two sides, so turn the pill over and check both.
- It is orange, capsule, 14 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Sutent.
Ingredients
Active: Sunitinib Malate
Inactive: Mannitol, Croscarmellose Sodium, Povidone K25, Magnesium Stearate, Gelatin, Unspecified, Titanium Dioxide, Ferric Oxide Red, Shellac, Propylene Glycol, Sodium Hydroxide, Povidone, Unspecified, Potassium Hydroxide
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
SD TC 1 mg
Tacrolimus 1 mg
Orange & yellow, capsule, 14 mm
Used for eczema
-
423
Telmisartan and Hydrochlorothiazide 40 mg / 12.5 mg
Orange & white, capsule, 15 mm
Used for high blood pressure
-
B15
Cyclobenzaprine Hydrochloride 15 mg
Orange, capsule, 14 mm
Used for muscle stiffness (spasticity) and muscle spasms
-
B15
Cyclobenzaprine HCl ER 15 mg
Orange, capsule, 14 mm
Used for pain
-
B15
Cyclobenzaprine HCl 15 mg
Orange, capsule, 14 mm
Used for muscle stiffness (spasticity) and muscle spasms
-
R 30
Captopril and Hydrochlorothiazide 50 mg / 25 mg
Orange, capsule, 15 mm
Used for high blood pressure
Other Sunitinib Malate pills
- SC 12 5 Sunitinib Malate 12.5 mg Gray, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- MYLAN SM 12 5 Sunitinib Malate 12.5 mg Pink, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- STN 12 5 Sunitinib Malate 12.5 mg Yellow, capsule, 11 mm Used for renal cell carcinoma and pancreatic neoplasms
- RM53 RM53 Sunitinib Malate 12.5 mg Brown, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- S12 5 Sunitinib Malate 12.5 mg Red, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- 6 MS Sunitinib Malate 12.5 mg Orange, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- TEVA 8199 TEVA 8199 Sunitinib Malate 12.5 mg Red, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- TEVA 8199 Sunitinib Malate 12.5 mg Red, capsule Used for renal cell carcinoma and pancreatic neoplasms